Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes

被引：7
|
作者：
Lee, J. -Y. [1 ,2 ]
Cho, Y. [1 ,2 ]
Lee, M. [1 ,2 ]
Lee, Y. -H. [1 ,2 ,3 ]
Lee, B. -W. [1 ,2 ,3 ]
Kang, E. S. [1 ,2 ,3 ]
Cha, B. -S. [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Grad Sch, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Inst Endocrine Res, Coll Med, Seoul, South Korea
来源：
DIABETES & METABOLISM | 2018年 / 44卷 / 05期
关键词：
INSULIN-RESISTANCE; DOUBLE-BLIND; PIOGLITAZONE; TOLERABILITY; METFORMIN; THERAPY; VILDAGLIPTIN; MONOTHERAPY; 24-WEEK;
D O I：
10.1016/j.diabet.2017.11.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：452 / 455
页数：4
相关论文
共 50 条
  • [41] Efficacy and Safety of Saxagliptin Combination Therapy in US Patients with Type 2 Diabetes
    Karyekar, Chetan
    Donovan, Mark
    Allen, Elsie
    Fleming, Douglas
    Ravichandran, Shoba
    Chen, Roland
    POSTGRADUATE MEDICINE, 2011, 123 (04) : 63 - 70
  • [42] Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis
    Colmers, I. N.
    Bowker, S. L.
    Johnson, J. A.
    DIABETES & METABOLISM, 2012, 38 (06) : 475 - 484
  • [43] Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin
    Bolli, G.
    Dotta, F.
    Colin, L.
    Minic, B.
    Goodman, M.
    DIABETES OBESITY & METABOLISM, 2009, 11 (06) : 589 - 595
  • [44] Efficacy and safety of metformin for treatment of type 2 diabetes in elderly Japanese patients
    Ito, Hiroyuki
    Ohno, Yasuhiro
    Yamauchi, Takaaki
    Kawabata, Yumiko
    Ikegami, Hiroshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2011, 11 (01) : 55 - 62
  • [45] Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
    Guja, Cristian
    Frias, Juan P.
    Suchower, Lisa
    Hardy, Elise
    Marr, Galina
    Sjostrom, C. David
    Jabbour, Serge A.
    DIABETES THERAPY, 2020, 11 (07) : 1467 - 1480
  • [46] Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
    Ferrannini, E.
    Fonseca, V.
    Zinman, B.
    Matthews, D.
    Ahren, B.
    Byiers, S.
    Shao, Q.
    Dejager, S.
    DIABETES OBESITY & METABOLISM, 2009, 11 (02) : 157 - 166
  • [47] Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
    Varshney, Amit
    Rawat, Ramakant
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (08):
  • [48] Secretory units of islets in transplantation index is a useful clinical marker to evaluate the efficacy of sitagliptin in treatment of type 2 diabetes mellitus
    Kubota, Akira
    Matsuba, Ikuro
    Saito, Tatsuhiko
    Nabe, Koichiro
    Seino, Yutaka
    JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (05) : 377 - 380
  • [49] Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial
    Ferreira, Juan C. Arjona
    Corry, Dalila
    Mogensen, Carl E.
    Sloan, Lance
    Xu, Lei
    Golm, Gregory T.
    Gonzalez, Edward J.
    Davies, Michael J.
    Kaufman, Keith D.
    Goldstein, Barry J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : 579 - 587
  • [50] Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus
    Scheen, Andre J.
    Charpentier, Guillaume
    Ostgren, Carl Johan
    Hellqvist, Asa
    Gause-Nilsson, Ingrid
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (07) : 540 - 549
12345